2024 SCAI SHOCK

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

Sponsored by SCAI. Supported by Chiesi.

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.​

SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.​

Case, Part 1
Adnan Khalif, M.D., FSCAI, Allegheny General Hospital, Pittsburgh, PA
Pharmacodynamics of Antiplatelet Therapies in CS?
Sarah Gorgis, MD, The Cleveland Clinic Foundation, Cleveland, OH
Cangrelor in AMI & CS
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
Optimal Antiplatelet Strategies in High-Risk Patients?
Greg W Serrao, MD, FSCAI, Icahn School of Medicine at Mount Sinai, New York, NY
Case, Part 2
Adnan Khalif, M.D., FSCAI, Allegheny General Hospital, Pittsburgh, PA